GTR 101231720
Bids Are Invited For Acquisition Of Bevacizumab 100Mg Injectable Solution 4 Ml Vial 4 Mg, Zoledronic Acid 4 Mg Fa, Cyclobenzaprine 5 Mg Tablet, Atropin (Sulfate) 1% Ophthalmic Solution 5 Ml, Fluorescein (Sodium) 20% Solution Fa 5 Ml, Carbacol 0.01% Sol Inj Intravitrereal Bottle 2 Ml, Deserroxamine (Mesylate) 500 Mg Lyophilized Powder Fa.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
101231720
Tendering Authority
Subscribe to view
Tender No
90745/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Bevacizumab 100Mg Injectable Solution 4 Ml Vial 4 Mg, Zoledronic Acid 4 Mg Fa, Cyclobenzaprine 5 Mg Tablet, Atropin (Sulfate) 1% Ophthalmic Solution 5 Ml, Fluorescein (Sodium) 20% Solution Fa 5 Ml, Carbacol 0.01% Sol Inj Intravitrereal Bottle 2 Ml, Deserroxamine (Mesylate) 500 Mg Lyophilized Powder Fa.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
11-09-2025
Closed
Work Detail
Acquisition Of Bevacizumab 100Mg Injectable Solution 4 Ml Vial 4 Mg, Zoledronic Acid 4 Mg Fa, Cyclobenzaprine 5 Mg Tablet, Atropin (Sulfate) 1% Ophthalmic Solution 5 Ml, Fluorescein (Sodium) 20% Solution Fa 5 Ml, Carbacol 0.01% Sol Inj Intravitrereal Bottle 2 Ml, Deserroxamine (Mesylate) 500 Mg Lyophilized Powder Fa.. Bevacizumab, Zoledronic Acid, Cyclobenzaprine Hydrochloride, Sulfate Atropine, Fluorescein, Carbacol, Deserferroxamine Mesylate
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
436eae6e-aba1-489e-9335-0f11917bb8d3.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.